Immediate Impact
3 from Science/Nature 54 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Therapeutic advances in rheumatoid arthritis
2024 Standout
Works of Brett E. Houk being referenced
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL : Analyses of Phase I Clinical Trials
2023
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Brett E. Houk | 933 | 701 | 590 | 47 | 1.6k | |
| Laurie Sherman | 1211 | 468 | 1042 | 41 | 1.8k | |
| Remy B. Verheijen | 519 | 772 | 618 | 50 | 1.3k | |
| Maria Luisa Veronese | 956 | 334 | 672 | 35 | 1.8k | |
| A. Benjamin Suttle | 629 | 685 | 733 | 36 | 1.5k | |
| N. Schleucher | 591 | 601 | 789 | 32 | 1.6k | |
| Paul K. Stockman | 791 | 717 | 916 | 39 | 1.8k | |
| Dana T. Aftab | 794 | 567 | 869 | 45 | 1.8k | |
| Katherine Liau | 858 | 833 | 1082 | 36 | 2.0k | |
| L. Austin Doyle | 1042 | 832 | 872 | 71 | 2.2k | |
| Francisco Javier Ramos | 764 | 414 | 616 | 40 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...